Why the study?
Does rhASB effectively target chondroitin sulfate glycosaminoglycans to treat cardiac fibrosis and heart failure?
Does rhASB effectively target chondroitin sulfate glycosaminoglycans to treat cardiac fibrosis and heart failure?
Targeting chondroitin sulfate glycosaminoglycans with rhASB represents a potential novel therapeutic approach for treating cardiac fibrosis and heart failure.
No takes yet. Share an insight, caveat, or question.
Should not change practice yet; hypothesis-generating for rhASB in cardiac fibrosis.
Zhao et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: